Get started
Author

Małgorzata Fuksiewicz

Observed names: M. Fuksiewicz, Malgorzata Fuksiewicz
ORCID: 0000-0001-9625-423X
Observed ORCID: 0000-0001-9625-423X
OpenAlex ID: A5077493754
The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease
2015 · Beata Kotowicz, Malgorzata Fuksiewicz, et al. · Tumor Biology · 48
PDF
Serum markers in early-stage and locally advanced melanoma
2015 · Iwona Lugowska, Maria Kowalska, et al. · Tumor Biology · 39
PDF
Pretreatment neutrophil to lymphocyte and platelet to lymphocyte ratios as predictive factors for the survival of cervical adenocarcinoma patients
2018 · Joanna Jonska-Gmyrek, Leszek Gmyrek, et al. · Cancer Management and Research · 36
PDF
Prognostic value of chromogranin A in patients with GET/NEN in the pancreas and the small intestine
2018 · Małgorzata Fuksiewicz, Maria Kowalska, et al. · Endocrine Connections · 27
PDF
Clinical significance of pretreatment serum levels of VEGF and its receptors, IL- 8, and their prognostic value in type I and II endometrial cancer patients
2017 · Beata Kotowicz, Malgorzata Fuksiewicz, et al. · PLoS ONE · 27
PDF
Preoperative serum levels of YKL 40 and CA125 as a prognostic indicators in patients with endometrial cancer
2017 · Beata Kotowicz, Malgorzata Fuksiewicz, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 24
Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer
2010 · Malgorzata Fuksiewicz, Maria Kowalska, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 20
Radiotherapy and radiochemotherapy increase serum levels of pro-inflammatory interleukin-6 and C-reactive protein in patients with head and neck cancers
2018 · Dorota Kiprian, Bozena Czarkowska-Paczek, et al. · Translational Cancer Research · 16
The Assessment of Clinical Usage and Prognostic Value of YKL-40 Serum Levels in Patients With Rectal Cancer Without Distant Metastasis
2018 · Malgorzata Fuksiewicz, Beata Kotowicz, et al. · Technology in Cancer Research & Treatment · 16
Serum macrophage colony-stimulating factor (M-CSF) in patients with Hodgkin lymphoma
2011 · Maria Kowalska, Joanna Tajer, et al. · Medical Oncology · 16
Procollagen I amino-terminal propeptide as a potential marker for multiple myeloma
2010 · Maria Kowalska, Agnieszka Druzd-Sitek, et al. · Clinical Biochemistry · 14
Clinical value of human epididymis protein 4 and the Risk of Ovarian Malignancy Algorithm in differentiating borderline pelvic tumors from epithelial ovarian cancer in early stages
2015 · Beata Kotowicz, Malgorzata Fuksiewicz, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 13
The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis
2014 · Malgorzata Fuksiewicz, Beata Kotowicz, et al. · Tumor Biology · 13
CXCR4/ACKR3/CXCL12 axis in the lymphatic metastasis of vulvar squamous cell carcinoma
2021 · Natalia Rusetska, Kamil Kowalski, et al. · Journal of Clinical Pathology · 11
PDF
Discriminant analysis involving serum cytokine levels and prediction of the response to therapy of patients with Hodgkin lymphoma
2012 · Maria Kowalska, Joanna Tajer, et al. · Tumor Biology · 10
A survey of prognostic value of serum factors in multiple myeloma patients before treatment: macrophage-colony stimulating factor (M-CSF) is a powerful predictor of survival
2009 · Maria Kowalska, Janina Kaminska, et al. · Medical Oncology · 10
Prognostic value of coronary atherosclerosis and CAC score for the risk of chemotherapy-related cardiac dysfunction (CTRCD): The protocol of ANTEC study
2023 · Anna Borowiec, Patrycja Ozdowska, et al. · PLoS ONE · 9
PDF
Serum levels of neuron-specific enolase as a prognostic factor for disease progression in patients with GET/NEN in the pancreas and the small intestine
2022 · Malgorzata Fuksiewicz, Maria Kowalska, et al. · Endocrine Connections · 9
PDF
The Impact of Dietary Counselling on Achieving or Maintaining Normal Nutritional Status in Patients with Early and Locally Advanced Breast Cancer Undergoing Perioperative Chemotherapy
2022 · Magdalena Jodkiewicz, Agnieszka Jagiełło-Gruszfeld, et al. · Nutrients · 8
PDF
Interleukin-6 as a Predictive Factor of Pathological Response to FLOT Regimen Systemic Treatment in Locally Advanced Gastroesophageal Junction or Gastric Cancer Patients
2024 · Katarzyna Marcisz-Grzanka, Beata Kotowicz, et al. · Cancers · 5
PDF
Evaluation of the Prognostic Value of Obesity, Vitamin D Concentrations, and Systemic Inflammatory Response Indexes (SIRI, SII, PIV) in Patients With Breast Cancer Scheduled for Neoadjuvant Treatment
2025 · Beata Kotowicz, Malgorzata Fuksiewicz, et al. · Breast Cancer Basic and Clinical Research · 4
Serous Carcinoma of the Uterine Cervix, an Extremely Rare Aggressive Entity: A Literature Review
2018 · Joanna Jonska-Gmyrek, Agnieszka Zolciak-Siwinska, et al. · Gynecologic and Obstetric Investigation · 4
Expression of Soluble Form of Aurora A as a Predictive Factor for Neoadjuvant Therapy in Breast Cancer Patients: A Single-Center Pilot Study
2023 · Pawel Winter, Malgorzata Fuksiewicz, et al. · Cancers · 3
PDF
Measurement of HE4 six months after first-line treatment as optimal time in identifying patients at high risk of progression advanced ovarian cancer
2022 · Beata U. Kotowicz, Malgorzata Fuksiewicz, et al. · Ginekologia Polska · 3
Neurofilaments as Prognostic Biomarkers in the Assessment of the Risk of Advanced Taxane-Induced Neuropathy in Breast Cancer Patients—A Pilot Study
2025 · Agata Makówka, Malgorzata Fuksiewicz, et al. · Cancers · 2
Works count: 40
Citation count: 392
H-index: 13
I10-index: 16
Year
Topic
Type